These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31958922)

  • 1. Therapy-related acute myeloid leukemia secondary to histiocytic sarcoma.
    Wu W; Jing Y; Xu Q; Hao J
    Minerva Med; 2021 Oct; 112(5):655-657. PubMed ID: 31958922
    [No Abstract]   [Full Text] [Related]  

  • 2. After the treated mole.
    Rashidi A; Maherus EM
    Blood; 2014 May; 123(18):2757. PubMed ID: 24904937
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)].
    Robak T; Krykowski E; Płuzańska A; Olszańska-Skorek T; Urbańska-Ryś H; Polkowska-Kulesza E; Błasińska-Morawiec M; Mazurowa A
    Pol Tyg Lek; 1983 Apr; 38(16):481-4. PubMed ID: 6579509
    [No Abstract]   [Full Text] [Related]  

  • 4. Double recurrence of double cancers: Rhabdomyosarcoma and secondary AML.
    Kajita N; Saito Y; Makimoto A; Miyahara S; Yuza Y
    Pediatr Int; 2020 Jun; 62(6):742-744. PubMed ID: 32495974
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
    Scholz M; Engert A; Franklin J; Josting A; Diehl V; Hasenclever D; Loeffler M
    Ann Oncol; 2011 Mar; 22(3):681-688. PubMed ID: 20720088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study.
    Clin Adv Hematol Oncol; 2016 Feb; 14(2 Suppl 1):9-10. PubMed ID: 27007004
    [No Abstract]   [Full Text] [Related]  

  • 7. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.
    Heyn R; Khan F; Ensign LG; Donaldson SS; Ruymann F; Smith MA; Vietti T; Maurer HM
    Med Pediatr Oncol; 1994; 23(2):99-106. PubMed ID: 8202048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
    Bhatia S; Krailo MD; Chen Z; Burden L; Askin FB; Dickman PS; Grier HE; Link MP; Meyers PA; Perlman EJ; Rausen AR; Robison LL; Vietti TJ; Miser JS
    Blood; 2007 Jan; 109(1):46-51. PubMed ID: 16985182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Four cases of therapy-related leukemia in multiple myeloma].
    Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.
    Tesch H; Diehl V; Lathan B; Hasenclever D; Sieber M; Rüffer U; Engert A; Franklin J; Pfreundschuh M; Schalk KP; Schwieder G; Wulf G; Dölken G; Worst P; Koch P; Schmitz N; Bruntsch U; Tirier C; Müller U; Loeffler M
    Blood; 1998 Dec; 92(12):4560-7. PubMed ID: 9845521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas.
    Olszewski AJ; Reagan JL; Castillo JJ
    Am J Hematol; 2018 Jan; 93(1):E1-E3. PubMed ID: 28960532
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
    Eichenauer DA; Thielen I; Haverkamp H; Franklin J; Behringer K; Halbsguth T; Klimm B; Diehl V; Sasse S; Rothe A; Fuchs M; Böll B; von Tresckow B; Borchmann P; Engert A
    Blood; 2014 Mar; 123(11):1658-64. PubMed ID: 24478403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary leukemia in a child conceived using in vitro fertilization.
    Kim YD; Kim KJ; Lee YH
    Pediatr Int; 2008 Dec; 50(6):831-2. PubMed ID: 19067904
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy-related leukemia with a novel 21q22 rearrangement.
    Izumi T; Ohtsuki T; Ohya K; Ogawa Y; Yoshida M; Muroi K; Imagawa S; Hatake K; Kuriki K; Saito K; Miura Y
    Cancer Genet Cytogenet; 1996 Aug; 90(1):45-8. PubMed ID: 8780746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute myeloid leukemia six years after chemotherapy of Hodgkin's disease].
    Fujii H; Yashige H; Maekawa T; Horiike S
    Rinsho Ketsueki; 1988 Dec; 29(12):2369-74. PubMed ID: 3246723
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
    Bajorin DF; Motzer RJ; Rodriguez E; Murphy B; Bosl GJ
    J Natl Cancer Inst; 1993 Jan; 85(1):60-2. PubMed ID: 7677936
    [No Abstract]   [Full Text] [Related]  

  • 18. Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy.
    Yokoo M; Kojima K; Sano H; Kai K; Arakawa F; Ohshima K; Matsunaga T; Kimura S
    Ann Hematol; 2019 Jun; 98(6):1501-1503. PubMed ID: 30406822
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy-related acute myeloid leukemia with t(8;21) in a child with previous Ewing's sarcoma.
    Lesesve JF; Schneider P; Dolgopolov I; Bastard C; Lenormand B; Cambon-Michot E; Callat MP; Cavelier B; Tron PH; Vannier JP
    Med Pediatr Oncol; 1997 Aug; 29(2):132-4. PubMed ID: 9180915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].
    Shi YK; Yang S; Han XH; Ma J; Ren HY; Cen XN; Zhou SY; Wang C; Jiang WQ; Huang HQ; Wang JM; Zhu J; Chen H; Han MZ; Huang H; Shen XM; Liu P; He XH
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):592-6. PubMed ID: 20021946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.